Antibody Responses, Amyloid-#946; Peptide Remnants and Clinical Effects of AN-1792 Immunization in Patients with AD in an Interrupted Trial

Publisher: Bentham Science Publishers

E-ISSN: 1996-3181|8|2|88-97

ISSN: 1871-5273

Source: CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.8, Iss.2, 2009-04, pp. : 88-97

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content